baber/WOPTO huggingface dataset:
Patent AU-4510697-A (AU)
Title: Filter with mounting frame and mounting devices
Inventor: ODLING PATRICK
IPC: B01D46/02
Filed: 1997-04-16
Abstract: The invention relates to a device in air filter cartridges of so-called bag filter type. By means of making recesses (15) in the short sides of the respective filter blanks, before sewing, a seam line/supporting line (17) is obtained which is lower than the corner side portions (18) of the filter blank (16). In this way, the pressure/tensile load may be distributed over the entire area at the entrance of the air filter cartridge by means of a wire grating inserted in the cartridge frame.
Patent AU-4523501-A (AU)
Title: Oscillator having multi-phase complementary outputs
Inventor: AFGHAHI MORTEZA CYRUS
IPC: H03K3/03
Filed: 2000-12-12
Abstract: An oscillator having multi-phase complementary outputs comprises a first plurality of single ended amplifiers connected in series to form an input and an output and a second plurality of single ended amplifiers connected in series to form an input and an output. The first and second plurality have the same odd number of amplifiers. A first feedback path connects the output to the input of the first plurality of amplifiers to establish oscillations in the first plurality of amplifiers at a frequency dependent upon the delay time from the input to the output of the first plurality. A second feedback path connects the output to the input of the second plurality of amplifiers to establish oscillations in the second plurality of amplifiers at a frequency dependent upon the delay time from the input to the output of the second plurality. A first locking circuit is connected between comparable first points in the first and second plurality of amplifiers to ensure that the first points are oscillating in complementary fashion and a second locking circuit is connected between comparable second points in the first and second plurality of amplifiers to ensure that the second points are oscillating in complementary fashion.
Patent AU-4728500-A (AU)
Title: Document transfer device
Inventor: KING TOBIN ALLEN
IPC: B41J2/175
Filed: 2000-05-24
Abstract: A system is provided having a sensing device for sensing coded data printed on a print media surface which is installed with a secret key and a first identifier which uniquely identifies the sensing device, a printer installed with a second identifier which uniquely identifies the printer, and a server installed with the first and second identifiers. The printer obtains the first identifier from the sensing device and communicates the first and second identifiers to the server. The server determines from the received first and second identifiers whether the sensing device should be registered with the printer and if so, authenticates the sensing device by verifying an encryption from the sensing device, using the secret key, of a challenge message. Upon successful authentication, the sensing device is registered in the server so as to be associated with the printer.
Patent AU-4755090-A (AU)
Title: Minimizing deactivation of ether synthesis catalyst
Inventor: CIKUT JOHN JOSEPH
IPC: B01J20/20
Filed: 1989-11-21
Abstract: A method for producing alkyl tertiary alkyl ether involves supplying a feed including isoolefins, alcohols, and dialkyl sulfides into a feed zone of a reactor; contacting the feed with a catalyst material in the reaction zone; and catalytically reacting the isooolefins and alcohols under conditions which favor forming resultant ether and inhibiting reaction of dialkyl sulfides with the catalyst material.
Patent AU-4816293-A (AU)
Title: Epstein-barr virus peptides and antibodies against these peptides
Inventor: MIDDELDORP JAAP MICHIEL
IPC: G01N33/53
Filed: 1993-09-13
Abstract: PCT No. PCT/EP93/02478 Sec. 371 Date May 11, 1994 Sec. 102(e) Date May 11, 1994 PCT Filed Sep. 13, 1993 PCT Pub. No. WO94/06912 PCT Pub. Date Mar. 31, 1994The invention relates to a peptide or fragment thereof which is immunochemically reactive with Epstein-Barr Virus (EBV) antibodies. A new monoclonal antibody directed to said peptide or fragment thereof is also part of the invention. The invention also relates to a method for the detection of EBV or anti-EBV antibodies in a test fluid and also to an immunochemical reagent comprising a peptide, a fragment or a polypeptide according to the invention and a test kit to be used when applying the said detection methods. Detection of EBV in a test fluid or tissue specimen using antibodies, monoclonal and polyclonal; directed to the said peptide, which have the characteristics of detecting both native and denatured intact, functional EBNA-1 protein is also part of said invention.
Patent AU-4901785-A (AU)
Title: Child resistant closure
IPC: B65D55/02
Filed: 1985-10-24
Abstract: A bottle with a neck (1) has a child-resistant screw closure cap (13). In order to make the cap (13) child-resistant, the neck (1) is fitted with a collar (7) of U-shaped cross- section. The collar (7) is retained on the neck (1) by engagement of pawls (11) inside a portion (8) of the collar under a retaining ring (2) on the neck (1). The cap (13) is screwed onto the part (8) of the collar and to allow this to be done, the collar (7) is prevented from rotating on the neck (1) by engagement of the pawls (11) with ratchet teeth (4) on the outside of the neck (1). The pawls (11) and the ratchet teeth (4) are so shaped that if an attempt is made to unscrew the cap (13) merely by turning it in a counter-clockwise direction as seen from above, the pawls (11) ride over the ratchet teeth (4) so that the collar (7) is lifted on the neck (1) and is free to rotate. To enable the cap (13) to be unscrewed, the cap must be pressed downwards while it is rotated in a counter-clockwise direction to hold the pawls (11) in engagement with the ratchet teeth (4) and thus prevent the collar (7) from turning on the neck (1).
Patent AU-4923993-A (AU)
Title: Calcium phosphate hydroxyapatite precursor and methods for making and using the same
Inventor: CHOW LAURENCE C
IPC: A61K6/838
Filed: 1993-09-15
Abstract: Calcium phosphate compositions that are particularly useful and unique as orthopedic and dental cements and remineralizers, as well as methods and kits for their use, and the resulting products are disclosed. The compositions comprise tetracalcium phosphate which has been prepared from a mixture with a calcium to phosphorous ratio of less than 2, or prepared and maintained under substantially anhydrous conditions prior to use or, preferably, both. The novel compositions are converted substantially to hydroxyapatite upon setting, are substantially gradually resorbable and replaced by bone when implanted in contact with living bony tissue, and offer distinct advantages in terms of cement strength, setting time and reliability and other properties.
Patent AU-4995599-A (AU)
Title: Ultrathin optical panel and a method of making an ultrathin optical panel
Inventor: BISCARDI CYRUS
IPC: H04N5/74
Filed: 1999-07-14
Abstract: An ultrathin optical panel, and a method of producing an ultrathin optical panel, are disclosed, including stacking a plurality of glass sheets, which sheets may be coated with a transparent cladding substance or may be uncoated, fastening together the plurality of stacked coated glass sheets using an epoxy or ultraviolet adhesive, applying uniform pressure to the stack, curing the stack, sawing the stack to form an inlet face on a side of the stack and an outlet face on an opposed side of the stack, bonding a coupler to the inlet face of the stack, and fastening the stack, having the coupler bonded thereto, within a rectangular housing having an open front which is aligned with the outlet face, the rectangular housing having therein a light generator which is optically aligned with the coupler. The light generator is preferably placed parallel to and proximate with the inlet face, thereby allowing for a reduction in the depth of the housing.
Patent AU-5078600-A (AU)
Title: DNA vaccine - PVC
Inventor: AUDONNET JEAN-CHRISTOPHE FRANC
IPC: A01N63/00
Filed: 2000-06-08
Abstract: The invention relates to immunogenic preparations or vaccines comprising, on the one hand, a plasmid encoding and expressing a gene from PCV, in particular selected from the group consisting of ORF1 of PCV-2, ORF2 of PCV-2, ORF1 of PCV-1 and ORF2 of PCV-1, and, on the other hand, an element capable of increasing the immune response directed against the product of expression of the gene, which can be a carbomer, a porcine cytokine, e.g. GM-CSF or a cationic lipid of formula in which R<SUB>1 </SUB>is a saturated or unsaturated linear aliphatic radical having from 12 to 18 carbon atoms, R<SUB>2 </SUB>is another aliphatic radical comprising from 2 to 3 carbon atoms, andt X is an hydroxyle ou amine group. The cationic lipid can be DMRIE, possibly coupled with DOPE.
Patent AU-5121590-A (AU)
Title: Plasmodium merozoite rhoptries antigen and derivatives thereof
IPC: C07K14/00
Filed: 1990-03-09
Abstract: The invention is concerned with antigenic polypeptides having a determinant or determinants immunologically cross-reactive with determinants on a polypeptide associated with the rhoptry organelles of the merozoite form of the malaria parasite Plasmodium falciparum. Further, the invention is concerned with immunogenic compositions which contain such a polypeptide and a suitable adjuvant, with DNAs coding for such a polypeptide, recombinant vectors containing such a DNA sequence, unicellular host organisms which contain such a replicable vector as well as antibodies which are directed against a polypeptide in accordance with the invention. Furthermore. the invention is concerned with a process for the production of the immunogenic compositions, of the microorganisms and of the antibodies as well as with the use of the polypeptides and the immunogenic compositions for the immunization of mammals against malaria.
Patent AU-5203693-A (AU)
Title: Polyolefin molding composition for producing fibers, filaments and webs by melt spinning
Inventor: WINTER ANDREAS
IPC: C08L23/10
Filed: 1993-11-30
Abstract: A polyolefin moulding composition essentially comprising a polyolefin which comprises an olefin having at least 3 carbon atoms, of the formula R<a>-CH=CH-R<b>, in which R<a> and R<b> are identical or different and are hydrogen or straight-chain or branched C1-C15-alkyl, or R<a> and R<b>, together with the atoms connecting them, form a ring system, and from 0 to 10% by weight of ethylene or a second olefin as defined above as comonomer, characterised in that the MFI (230/2.16) is from 5 to 1000 g/10 min, the MFI (230/5) is from 15 to 3000 g/10 min, the molecular weight Mw is from 75,000 to 350,000 g/mol, the polydispersity Mw/Mn is from 1.8 to 3.5, the viscosity index is from 70 to 300 cm<3>/g, the melting point is from 120 to 165@C and the isotactic block length is from 25 to 150, and an ether-extractable content of less than 2% by weight, based on the total weight of the polymer.
Patent AU-5219386-A (AU)
Title: Pyridopyrimidines, several processes for their preparation and their use as medicaments
Inventor: MEYER HORST
IPC: A61K31/505
Filed: 1986-01-10
Abstract: Pyridopyrimidines of the formula   <IMAGE>   in which R1 is optionally substituted aryl or heterocyclic, exhibit circulation active properties, especially renal vasodilating and diuretic action.
Patent AU-5232190-A (AU)
Title: Novel compounds
Inventor: BATESON JOHN HARGREAVES
IPC: C07D501/56
Filed: 1990-03-28
Abstract: beta -Lactam compounds of the formula (Ia) including pharmaceutically acceptable salts and in vivo hydrolysable esters, processes for their preparation and their use as antibiotics: <CHEM>  wherein  R<1> is hydrogen, methoxy or formamido; R<2> is an acyl group, in particular that of an antibacterially active cephalosporin;  CO2R<6> is a carboxy group or a carboxylate anion; R<3> is a  gamma -lactone ring optionally containing an endocyclic double bond, which ring is optionally substituted at any carbon atom by alkyl, dialkylamino, alkoxy, hydroxy, halogen or aryl, which in the case of more than one substituent may be the same or different, or is optionally di-substituted at two adjacent carbon atoms, which are available for substitution, to form an aromatic fused bicyclic system; and X is S, SO, SO2, O or CH2.
Patent AU-5261479-A (AU)
Title: Hydrocortisone orthoesters
Inventor: BAUMGARTH MANFRED
IPC: C07J21/00
Filed: 1979-11-08
Abstract: Hydrocortisone orthoesters of the formula   <IMAGE>   wherein R1 and R2 are independently each H or CH3 and n is 1 or 2 possess antiphlogistic activity.
Patent AU-5313498-A (AU)
Title: Method and system for integration of several physical media for data communications
Inventor: FERNANDEZ JOSE FABIAN PLAZA
IPC: H04L29/06
Filed: 1997-10-23
Abstract: A method and apparatus implements bi-directional communications using the same or different physical media linking any two computing systems, nodes, employing routable protocols such as TCP/IP, IPX/SPX, etc., connected to a common network, allowing bi-directional communication between them. One of the physical media preferably has a wider bandwidth in one direction than another one of the physical media operating in the other direction. The present invention also provides for optimizing traffic between any two nodes by appropriately selecting communication paths based on either bandwidth or costs. Communication between any two nodes can be split between several different physical or logical paths to either increase the effective transmission bandwidth or to provide communication redundancy. A method and system implements an Integrated Virtual Interface (IVI) which combines in a single virtual interface at least two physical interfaces per communication node (one for each communication direction) in a transparent manner such that operations of level #3 and above in the ISO (International Organization for Standardization) OSI (Open Systems Interconnection) model for data communication protocols and the levels above #3 function as if a single bi-directional communication interface exists while the lower OSI levels #1 and #2 maintain all their standard functionality.
Patent AU-5462998-A (AU)
Title: Co-processed microcrystalline cellulose and calcium carbonate
Inventor: AUGELLO MICHAEL
IPC: A61K9/20
Filed: 1997-11-24
Abstract: Particulate pharmaceutical tablet excipient compositions comprising co-processed microcrystalline cellulose and particulate USP calcium carbonate having a particle size distribution of 7 to 22  mu m wherein the range of calcium carbonate to microcrystalline cellulose is 70:30 to 90:10.
Patent AU-5621794-A (AU)
Title: Dispenser
Inventor: CROSSDALE GARRY W
IPC: A47L15/44
Filed: 1993-12-14
Abstract: PCT No. PCT/CA93/00538 Sec. 371 Date Sep. 5, 1995 Sec. 102(e) Date Sep. 5, 1995 PCT Filed Dec. 14, 1993 PCT Pub. No. WO94/13187 PCT Pub. Date Jun. 23, 1994A dispenser for powdered, granular, pellet, briquette or tablet-like material is provided. The dispenser includes a dispenser head through which the material dissolved in water can be dispensed. A spray device is provided at the head to spray water onto the material provided in the dispenser head. A suspension device is provided to suspend a bag containing the material above the dispenser head. The bag in its suspended orientation has a fastener along the bottom end which closes the bottom end of the bag. The fastener is not, however, releasable until after the bag is mounted in the dispenser. Then the fastener is releasable to allow the contents thereof to fall by gravity onto the dispenser head. The dispenser provides a system, which normally avoids contact of the toxic contents of the bag with the user. At the same time, the only waste is in the form of a bag which may be made of recyclable plastic, hence minimizing waste associated with the system.
Patent AU-5625799-A (AU)
Title: Handover between mobile communication networks
Inventor: KALLIOKULJU JUHA
IPC: H04W36/14
Filed: 1999-09-09
Abstract: The invention relates to a method for handing over a connection between a first (NW1) and a second mobile communication network (NW2) in a wireless terminal (MS1). In the method, at least one data transmission connection is established for the purpose of transmitting information between the wireless terminal (MS1) and one said mobile communication network (NW1, NW2). In the first mobile communication network, the connection type is either connection-oriented (HSCSD) or connectionless (GPRS), and in the second mobile communication network (NW1, NW2), at least two traffic classes with different transmission features are defined and one of them is selected for the data transmission connection of the second mobile communication network (NW1, NW2). In the method, it is also examined what active data transmission connections the wireless terminal (MS1) has to the mobile communication network (NW1, NW2) handing over the connection. When handing over a connection from the first mobile communication network (NW1) to the second mobile communication network (NW2), the connection type of each active data transmission connection is examined, the traffic class corresponding to each active data transmission connection type is defined in the second mobile communication network (NW2), and a connection according to the defined traffic class is established for each data transmission connection in the second mobile communication network (NW2). When handing over a connection from the second mobile communication network (NW2) to the first communication network (NW1) the traffic class of each active data transmission connection is examined, the connection type corresponding to each active data transmission traffic class is defined in the first mobile communication network (NW1), and a connection according to the defined connection type is defined for each data transmission connection in the first mobile communication network (NW1).
Patent AU-5653294-A (AU)
Title: Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene
Inventor: PIGNARD ANNIE
IPC: C12N15/82
Filed: 1993-12-07
Abstract: The invention relates to the novel use of a sequence coding for a protein capable of degrading oxalic acid to select plant cells which have integrated a gene of interest, and a novel process for selecting, on oxalic acid, cells, calluses or plants transformed by this recombinant DNA.
Patent AU-5754901-A (AU)
Title: Low capacity chlorine gas feed system
Inventor: HARUCH DAVID
IPC: F17C13/04
Filed: 2001-05-07
Abstract: A switchover device for providing a continuous supply of a gas such as chlorine to a water system. The switchover device includes an outlet in communication with a chamber as well as with a vacuum source and two inlets also in communication with the chamber. The switchover device further contains a shuttle that may be positioned to isolate the first inlet, the second inlet, or neither inlet.
Patent AU-5803901-A (AU)
Title: Wing in ground effect vehicle with endplates
Inventor: ALLEN KEN R
IPC: B60V1/22
Filed: 2001-05-17
Abstract: A Wing In Ground Effect Vehicle has a pair of supercavitating endplates ( 17 ) which extend below the fuselage ( 2 ) such that they can be immersed in water during flight thereover. The endplates have a nose ( 28 ) defining a leading edge ( 20 ) and adapted to generate a supercavity. The endplates ( 17 ) typically pivot about a pivot axis P to provide a stabilising weathercock-type effect.
Patent AU-5999194-A (AU)
Title: Prevention and treatment of cytomegalovirus using aminopeptidase
Inventor: ZAIA JOHN A
IPC: G01N33/569
Filed: 1994-01-21
Abstract: A method for the prevention or treatment of human cytomegalovirus is described. Aminopeptidases, preferably in soluble form is administered exogenously to the patient. The invention involves the discovery that aminopeptidases are a CMV surface protein involved in post-binding events in the CMV infection process. The invention includes the discovery that AP, including specifically APN, on the surface of the virion and on the surface of the cell is involved in the CMV infection process.
Patent AU-6245390-A (AU)
Title: Recombinant aprotinin variants - genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
IPC: C12N15/09
Filed: 1990-09-12
Abstract: The present invention relates to recombinant aprotinin variants; to methods for preparing the described peptide variants as homogeneously processed secretion products in transformed yeasts, and to pharmaceutical compositions containing the recombinant aprotinin variants.
Patent AU-6260799-A (AU)
Title: Patient transport system
Inventor: HODGETTS GRAHAM L
IPC: A61G1/00
Filed: 1999-09-23
Abstract: A patient transport system for transporting a patient from a bed to a stretcher or vice versa, using a bed sheet and a conveyor attached to the bed or the stretcher. A first end of the sheet is removably attached to the conveyor and a second end of the sheet is free. The sheet is adapted to be positioned onto the patient supporting member of the bed or stretcher. The conveyor includes a roller received by bearings. The roller can be removably received by the bearings. The roller can also include a telescopic arrangement so that its length can be adjusted.
Patent AU-6284499-A (AU)
Title: Improved component mixing catheter
Inventor: EPSTEIN GORDON HOWARD
IPC: A61B17/00
Filed: 1999-10-01
Abstract: A dual catheter (360) for delivery of a two component sealant (22) such as a fibrinogen, has coaxial inner and outer catheters (372, 364) respectively, each of which conveys a sealant component (fibrinogen or thrombin). The dual catheter (360) has a mixing volume at its distal end to mix the sealant immediately prior to delivery. The inner catheter (366) is reciprocally movable to clear clogs from the mixing volume. Optional features include a channeled plug-like tip (366) to the inner catheter, and a malleable or resilient material at the distal tip (362) to resist tissue damage.